Cost analysis of GenoType® MTBDRplus and GenoType® MTBDRsl at the State Laboratory of São Paulo, Brazil
Related Experiment Video
Updated: Jul 20, 2025
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Lida Jouca de Assis Figueredo1, Aina Liz Alves César2, Lucilaine Ferrazoli3
1Universidade Federal de Minas Gerais, Faculdade de Medicina, Laboratório de Pesquisa em Micobactérias, Belo Horizonte, MG, Brasil.
Background:
We aimed to evaluate the costs of GenoType® MTBDRplus and MTBDRsl incurred during the diagnosis of first- and second-line drug-resistant tuberculosis (TB) in São Paulo, Brazil.
Methods:
Mean and activity-based costs of GenoType® were calculated in a referral laboratory for TB in Brazil.
Results:
The mean cost value and activity-based cost of GenoType® MTBDRplus were USD 19.78 and USD 35.80 and those of MTBDRsl were USD 54.25 and USD 41.85, respectively.
Conclusions:
The cost of GenoType® MTBDRplus was reduced owing to the high number of examinations performed and work optimization.
